Organic compounds comprising a glycopyrronium salt

Details for Australian Patent Application No. 2006314724 (hide)

Owner Novartis AG

Inventors Collingwood, Stephen Paul; Haeberlin, Barbara

Agent Davies Collison Cave

Pub. Number AU-A-2006314724

PCT Pub. Number WO2007/057223

Priority 0523654.2 21.11.05 GB

Filing date 20 November 2006

Wipo publication date 24 May 2007

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/057223 Priority application(s): WO2007/057223

17 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006314726-Process for making montelukast and intermediates therefor

2006314723-Organic compounds comprising a glycopyrrolium salt